AstraZeneca resumes COVID-19 vaccine trials in UK; awaits regulators elsewhere
AstraZeneca has resumed UK clinical trials for its Oxford coronavirus vaccine, having paused all trials last week for a safety review. Other late-stage global trials, however, remain on hold while AstraZeneca waits for regulators in each market.
View the full story here: https://www.biopharma-reporter.com/Article/2020/09/14/AstraZeneca-resumes-COVID-19-vaccine-trials-in-UK-awaits-regulators-elsewhere